Clinical utility of valsartan in the treatment of hypertension in children and adolescents

References

• BurnierMBrunnerHRAngiotensin II receptor antagonistsLancet200035563764510696996
   PubMed Web of Science ®Google Scholar
• ChioleroABurnierMPharmacology of valsartan, an angiotensin II receptor antagonistExpert Opin Investig Drug1998719151925
   PubMedGoogle Scholar
• HabtemariamBSallasWSunkaraGKernSJarugulaVPillaiGPopulation pharmacokinetics of valsartan in pediatricsDrug Metab Pharmacokinet20092414515219430170
   PubMed Web of Science ®Google Scholar
• WernerCBaumhakelMTeoKKRAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selectionClin Res Cardiol20089741843118454336
   PubMed Web of Science ®Google Scholar
• Hernandez-HernandezRSosa-CanacheBVelascoMArmas-HernandezMJArmas-PadillaMCCammarataRAngiotensin II receptor antagonists role in arterial hypertensionJ Hum Hypertens200216S93S9911986904
   PubMed Web of Science ®Google Scholar
• BoozGWBakerKMRole of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophyHypertension1996286356408843890
   PubMed Web of Science ®Google Scholar
• StollMSteckelingsMPaulMBottariSPMetgerRUngerTThe angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cellsJ Clin Invest1995956516577860748
   PubMed Web of Science ®Google Scholar
• BarrerasAGurk-TurnerCAngiotensin II receptor blockersBUMC Proc200316123126
   Google Scholar
• CherryDKWoodwellDANational Ambulatory Medical Care Survey: 2000 summaryAdvance Data200232813212661586
   PubMedGoogle Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and AdolescentsThe fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescentsPediatrics200411455557615286277
   PubMed Web of Science ®Google Scholar
• RobinsonRFBatiskyDLHayesJRNahataMCMahanJDBody mass index in primary and secondary pediatric hypertensionPediatr Nephrol2004191379138415503182
   PubMed Web of Science ®Google Scholar
• PludowskiPLitwinMSladowskaJBone mass and body composition in children and adolescents with primary hypertensionHypertension200851778317984369
   PubMed Web of Science ®Google Scholar
• McGavockJMTorranceBMcGuireKAWoznyPLewanczukRZThe relationship between weight gain and blood pressure in children and adolescentsAm J Hypertens2007201038104417903685
   PubMed Web of Science ®Google Scholar
• Urrutia-RojasXEgbuchunamCUBaeSHigh blood pressure in school children: prevalence and risk factorsBMC Pediatrics20066323817109750
   PubMedGoogle Scholar
• HiramatsuKYamadaTIchikawakTIzumiyamaTNagataHChanges in endocrine activity to obesity in patients with essential hypertensionJ Am Geriatr Soc19812925307005295
   PubMed Web of Science ®Google Scholar
• TuckMISowersJDornfieldLKledzikGMaxwellMThe effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone level in obese patientsN Engl J Med19813049309337010165
   PubMed Web of Science ®Google Scholar
• RocchiniAPChildhood obesity and blood pressure regulationPortmanRJSorofJMIngelfingerJRPediatric HypertensionTotowa, NJHumana Press2004307334
   Google Scholar
• SarzaniRSalviFDessi-FulgheriPRappeliARenin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humansJ Hypertens20082683184318398321
   PubMed Web of Science ®Google Scholar
• EngeliSBohnkeJGorzelniakKWeight loss and the renin-angiotensin-aldosterone systemHypertension20054535636215630041
   PubMed Web of Science ®Google Scholar
• LaraghJLaragh’s lessons in pathophysiology and clinical pearls for treating hypertensionAm J Hypertens20011418619411243312
   PubMed Web of Science ®Google Scholar
• EganBMBasileJNRehmanSUPlasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trialAm J Hypertens20092279280119373213
   PubMed Web of Science ®Google Scholar
• RemuzziGPericoNMaciaMRuggenentiPThe role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseKidney Int200568S57S65
   Web of Science ®Google Scholar
• FlynnJTMitsnefesMPierceCfor the Chronic Kidney Disease in Children Study GroupBlood pressure in children with chronic kidney disease. A report from the Chronic Kidney Disease in Children StudyHypertension2008521718497371
   PubMed Web of Science ®Google Scholar
• WuhlETrivelliAPiccaSStrict blood pressure control and progression of renal failure in childrenN Engl J Med20093611639165019846849
   PubMed Web of Science ®Google Scholar
• FleschGMullerPLloydPAbsolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in manEur J Clin Pharmacol1997521151209174680
   PubMed Web of Science ®Google Scholar
• BlackHRBaileyJZappeDSamuelRValsartan: more than a decade of experienceDrugs2009692393241419911855
   PubMed Web of Science ®Google Scholar
• MeierCMSimonettiGDGhigliaSPalatability of angiotensin II antagonists among nephropathic childrenBr J Clin Pharmacol20076362863117302913
   PubMed Web of Science ®Google Scholar
• Diovan (valsartan) tablets [prescribing information]East Hanover, New JerseyNovartis Pharmaceuticals Corporation [cited 2008 Dec]. Available from: http://www.pharma.us.novartis.com/product/pi/pdf/diovan.pdf. Accessed February 16, 2011
   Google Scholar
• WellsTBlumerJLitwinMSafety and effectiveness of valsartan in hypertensive children ages 6–16 yearsJ Clin Hypertens (Greenwich)200795 Suppl AA79A80
   Google Scholar
• FlynnJTMeyersKECPacheco NetoJfor the Pediatric Valsartan Study GroupEfficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 yearsHypertension20085222222818591457
   PubMed Web of Science ®Google Scholar
• RodgersJEPattersonJHAngiotensin II-receptor blockers: clinical relevance and therapeutic roleAm J Health Syst Pharm20015867168311329759
   PubMed Web of Science ®Google Scholar
• YoungCHZhangKPoretAWPatterns of antihypertensive therapy in new users of angiotensin II-receptor blockersAm J Health Syst Pharm2005622381238516278329
   PubMed Web of Science ®Google Scholar
• WuhlESchaeferFTherapeutic strategies to slow chronic kidney disease progressionPediatr Nephrol20082370571618335252
   PubMed Web of Science ®Google Scholar
• SchaeferFMehlsOHypertension in chronic kidney diseasePortmanRJSorofJMIngelfingerJRPediatric HypertensionTotowa, NJHumana Press2004371387
   Google Scholar
• JafarTHSchmidCHLandaMACE inhibition in progressive renal disease study groupAngiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A metaanalysis of patient-level dataAnn Intern Med2001135738711453706
   PubMed Web of Science ®Google Scholar
• IzuharaYNangakuMInagiRRenoprotective properties of angiotensin receptor blockers beyond blood pressure loweringJ Am Soc Nephrol2005163631364116236804
   PubMed Web of Science ®Google Scholar
• SeemanTPohlMMisselwitzJJohnUAngiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with angiotensin-converting enzyme inhibitorsKidney Blood Press Res20093244044420016211
   PubMed Web of Science ®Google Scholar
• Clinical Trials Search. Worldwide Clinical Trials Listings. Hypertension. Available from: http://www.clinicaltrialssearch.org/extension-study-to-assess-long-term-safety-tolerability-and-efficacy-of-valsartan-and-enal-april-combined-and-alone-in-children-with-hypertension-nct00446511.html Accessed February 16, 2011
   Google Scholar
• ConlinPRSpenceJDWilliamsBAngiotensin II antagonists for hypertension: are there differences in efficacy?Am J Hypertens.2000134 Pt 141842610821345
   PubMed Web of Science ®Google Scholar
• WeinbergerMHGlazerRDCrikelairNAChiangYTAchieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapyJ Hum Hypertens20102482383020182456
   PubMed Web of Science ®Google Scholar
• SipahiIDebanneSMRowlandDYSimonDIFangJCAngiotensin-receptor blockade and risk of cancer: meta-analysis of randomized controlled trialsLancet Oncol20101162763620542468
   PubMed Web of Science ®Google Scholar